# Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial

> **NCT05041946** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 112 (actual)

## Conditions studied

- Fatigue
- Cancer

## Interventions

- **DRUG:** Methylphenidate
- **OTHER:** Placebo (Sugar Pill)

## Key facts

- **NCT ID:** NCT05041946
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07-16
- **Primary completion:** 2004-12-15
- **Final completion:** 2021-11-19
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2022-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05041946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05041946, "Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05041946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*